{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:44:43Z","timestamp":1782135883947,"version":"3.54.5"},"reference-count":31,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T00:00:00Z","timestamp":1519171200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2018,2,21]]},"DOI":"10.3233\/jnd-170272","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T12:36:57Z","timestamp":1513946217000},"page":"47-58","source":"Crossref","is-referenced-by-count":60,"title":["Long-Term Pulmonary Function in Duchenne Muscular Dystrophy: Comparison of Eteplirsen-Treated Patients to Natural History"],"prefix":"10.1177","volume":"5","author":[{"given":"T. Bernard","family":"Kinane","sequence":"first","affiliation":[{"name":"Division of Pediatric Pulmonary, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar H.","family":"Mayer","sequence":"additional","affiliation":[{"name":"Division of Pulmonology Pediatric Pulmonary, The Children\u2019s Hospital of Philadelphia, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra W.","family":"Duda","sequence":"additional","affiliation":[{"name":"Sarepta Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda P.","family":"Lowes","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nationwide Children\u2019s Hospital, Columbus, OH, USA"},{"name":"Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Moody","sequence":"additional","affiliation":[{"name":"PharPoint Research, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry R.","family":"Mendell","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nationwide Children\u2019s Hospital, Columbus, OH, USA"},{"name":"Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, Rochester, NY, USA"},{"name":"Department of Pediatrics and Neurology, Ohio State University, Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"1","key":"10.3233\/JND-170272_ref1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases\u2013a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.3233\/JND-170272_ref2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"issue":"10","key":"10.3233\/JND-170272_ref4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(09)70211-X","article-title":"Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: A single-blind, placebo-controlled, dose-escalation, proof-of-concept study","volume":"8","author":"Kinali","year":"2009","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.3233\/JND-170272_ref5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.nmd.2013.04.005","article-title":"Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: Results from the Muscular Dystrophy Association DMD Clinical Research Network","volume":"23","author":"Connolly","year":"2013","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.3233\/JND-170272_ref6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.3233\/JND-170272_ref7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: Implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.3233\/JND-170272_ref8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.57.4.645","article-title":"Diagnosis of Duchenne dystrophy by enhanced detection of small mutations","volume":"57","author":"Mendell","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.3233\/JND-170272_ref9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum Mutat"},{"key":"10.3233\/JND-170272_ref10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2015.05.008","article-title":"Exon skipping therapy for Duchenne muscular dystrophy","volume":"87","author":"Kole","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.3233\/JND-170272_ref11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/mt.2011.248","article-title":"Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy","volume":"20","author":"Cirak","year":"2012","journal-title":"Mol Ther"},{"issue":"2","key":"10.3233\/JND-170272_ref12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.24555","article-title":"Longitudinal effect of eteplirsen vs. historical control on ambulation in DMD","volume":"79","author":"Mendell","year":"2016","journal-title":"Ann Neurol"},{"issue":"5","key":"10.3233\/JND-170272_ref13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann Neurol"},{"issue":"1","key":"10.3233\/JND-170272_ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-9993(97)90001-0","article-title":"Clinical implications of maximal respiratory pressure determinations for individuals with Duchenne muscular dystrophy","volume":"78","author":"Hahn","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"10.3233\/JND-170272_ref15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.23808","article-title":"The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures","volume":"48","author":"Henricson","year":"2013","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.3233\/JND-170272_ref16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ppul.22847","article-title":"Respiratory muscle decline in Duchenne muscular dystrophy","volume":"49","author":"Khirani","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.3233\/JND-170272_ref17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ppul.23172","article-title":"Characterization of pulmonary function in Duchenne muscular dystrophy","volume":"50","author":"Mayer","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"5 Suppl","key":"10.3233\/JND-170272_ref18","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/00002060-199509001-00006","article-title":"Profiles of neuromuscular diseases. Limb-girdle syndromes","volume":"74","author":"McDonald","year":"1995","journal-title":"Am J Phys Med Rehabil"},{"issue":"2","key":"10.3233\/JND-170272_ref19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01241398-198803000-00002","article-title":"Pulmonary function and scoliosis in Duchenne dystrophy","volume":"8","author":"Miller","year":"1988","journal-title":"J Pediatr Ortho"},{"issue":"4","key":"10.3233\/JND-170272_ref20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1164\/rccm.201703-0507WS","article-title":"Pulmonary endpoints in Duchenne muscular dystrophy. A workshop summary","volume":"196","author":"Finder","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.3233\/JND-170272_ref21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"7","key":"10.3233\/JND-170272_ref22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1469-8749.2004.tb00508.x","article-title":"Height prediction from ulna length","volume":"46","author":"Gauld","year":"2004","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.3233\/JND-170272_ref23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.3233\/JND-170272_ref24","unstructured":"Polgar G , Varuni P . Pulmonary Function Testing in Children: Techniques and Standards. Philadelphia, PA: Saunders; 1971. p. 273."},{"issue":"7","key":"10.3233\/JND-170272_ref25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/thx.39.7.535","article-title":"Predicted normal values for maximal respiratory pressures in caucasian adults and children","volume":"39","author":"Wilson","year":"1984","journal-title":"Thorax"},{"key":"10.3233\/JND-170272_ref26","first-page":"1475","article-title":"Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: Current and emerging options","volume":"11","author":"LoMauro","year":"2015","journal-title":"Ther Clin Risk Manag"},{"issue":"15","key":"10.3233\/JND-170272_ref27","doi-asserted-by":"crossref","first-page":"E1009","DOI":"10.1097\/BRS.0b013e3181fea1ed","article-title":"The natural history of cardiac and pulmonary function decline in patients with duchenne muscular dystrophy","volume":"36","author":"Roberto","year":"2011","journal-title":"Spine"},{"issue":"4","key":"10.3233\/JND-170272_ref28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nmd.2016.12.014","article-title":"Characterization of pulmonary function in 10-18 year old patients with Duchenne muscular dystrophy","volume":"27","author":"Meier","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.3233\/JND-170272_ref29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.17925\/USN.2017.13.01.35","article-title":"Advances in pulmonary care in Duchenne muscular dystrophy","volume":"13","author":"Mayer","year":"2017","journal-title":"US Neurology"},{"issue":"2","key":"10.3233\/JND-170272_ref30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejpn.2011.07.001","article-title":"Motor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials","volume":"16","author":"Humbertclaude","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"issue":"12","key":"10.3233\/JND-170272_ref31","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1164\/ajrccm.164.12.2103052","article-title":"Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy","volume":"164","author":"Phillips","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"9979","key":"10.3233\/JND-170272_ref32","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/S0140-6736(15)60025-3","article-title":"Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): A double-blind randomised placebo-controlled phase 3 trial","volume":"385","author":"Buyse","year":"2015","journal-title":"Lancet"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-170272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:53:26Z","timestamp":1777506806000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-170272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,21]]},"references-count":31,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jnd-170272","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732381646.793560199","asserted-by":"object"}]},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,21]]}}}